Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)

Authors:	Ruff Christian T Giugliano Robert P Antman Elliott M Crugnale Sharon E Bocanegra Tomas Mercuri Michele Hanyok James Patel Indravadan Shi Minggao Salazar Dan McCabe Carolyn H Braunwald Eugene

Affiliation:	^a TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA ^b Daiichi Sankyo Inc, Parsippany, NJ

Abstract:

Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录！